Gastric Cardia Adenocarcinoma
NCI Definition: An adenocarcinoma that arises from the gastric cardia. The majority of cases have been reclassified as gastroesophageal junction adenocarcinomas. 
There is 1 clinical trial for gastric cardia adenocarcinoma, of which 0 are open and 1 is completed or closed. Of the trial that contains gastric cardia adenocarcinoma as an inclusion criterion, 1 is phase 1/phase 2 (0 open).
Carboplatin, fluorouracil, and leucovorin are the most common interventions in gastric cardia adenocarcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.